Public Control of the Diffusion of Health Technology
In this paper we will consider the opportunities for public control of the development and diffusion of medical technology. A number of authors in this volume point out the necessity of identifying cost-effective technologies. At the same time, although it is quite clear that identification is one significant step, it does not automatically mean that one will be able to stop the diffusion of inefficient technologies. In this contribution, we would like to discuss some of the factors behind problems related to the control of the diffusion of medical technology, review some of the experience with regulating diffusion, and derive from that some recommendations.
KeywordsTechnology Assessment Medical Technology Audit Committee Sickness Fund Social Insurance System
Unable to display preview. Download preview PDF.
- Buxton MJ, Acheson R, Caine N, Gibson S, O’Brien B (1985) Costs and benefits of the heart transplant programmes at Harefield and Papworth Hospitals. DHSS Research Report No 12, HMSO, LondonGoogle Scholar
- Groot LMJ, Lacronique JF, Stocking B (1983) Report of the second phase of the study of medical technology. Directorate General V, BrusselsGoogle Scholar
- Ludbrook A (1986) The role of economic appraisal in health service planning: new technologies. In: Drummond MF (ed) Economic appraisal of health technology in the European Community. Oxford University Press, OxfordGoogle Scholar
- Marmor TR, Christianson BJ (1982) Health care policy: a political economy approach. Sage, Beverly Hills, CAGoogle Scholar
- Rutten FFH (1985) Market strategies within a social insurance system. World Health Forum 6:15–17Google Scholar